Shares of Vicapsys Life Sciences, Inc. (OTCMKTS:VICP – Get Free Report) dropped 78.6% during mid-day trading on Monday . The stock traded as low as $1.50 and last traded at $1.50. Approximately 207 shares changed hands during trading, a decline of 76% from the average daily volume of 874 shares. The stock had previously closed at $7.00.
Vicapsys Life Sciences Stock Down 78.6 %
The company has a market cap of $48.11 million, a PE ratio of -50.00 and a beta of -4.14. The stock has a 50-day simple moving average of $1.51 and a 200 day simple moving average of $1.84.
Vicapsys Life Sciences (OTCMKTS:VICP – Get Free Report) last announced its quarterly earnings results on Friday, January 10th. The company reported ($0.01) earnings per share for the quarter.
About Vicapsys Life Sciences
Vicapsys Life Sciences, Inc focuses on the development and commercialization of VICAPSYN, a proprietary product. The company’s product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers.
See Also
- Five stocks we like better than Vicapsys Life Sciences
- How to buy stock: A step-by-step guide for beginners
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Earnings Per Share Calculator: How to Calculate EPS
- How Do Stock Buybacks Affect Shareholders?
- What is the Nikkei 225 index?
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Vicapsys Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicapsys Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
